Category

News
“We will probably do better with low volume, by focusing on niche APIs than with high volume ones,” he said, adding that a lot of other chemical processes in the manufacturing cycle would also have to be moved to India to cut costs in the long run.
Read More
GenWorks said it aims to double revenues in FY23 and the funding will be leveraged to cover working capital needs, relevant M&A to invest in manufacturing partnerships, and expansion in the area of in-vitro diagnostics. GenWorks, the Bengaluru-based startup that is dedicated to improving healthcare access in India, has raised a second round of funding...
Read More
Vikram Kelkar, MD, Hexagon Nutrition explains the widespread problem of Malnutrition and Food Fortification being one of the best solutions to combat the problem. This is inline to achieve UN SDGs 2 and 3 goals of Zero Hunger and Good Health & Well-being. #Malnutrition #FoodFortification
Read More
Hear Mayur Sirdesai’s view on Applications of Artificial Intelligence in Healthcare..
Read More
A pharmaceutical formulations and API manufacturing company. Established in 2006, Globela is an established ISO, FDCA – India and WHO cGMP accredited formulations manufacturing company with multiple therapeutic areas including oncology, anti-infectives, gastro, CVS, etc. and sales presence across 30+ countries. It is an experienced manufacturer for high quality semi-finished, finished dosages formulation and active...
Read More
Somerset Indus Capital Partners has picked up a minority stake in Gujarat-based Globela Pharma Pvt Ltd, marking the healthcare-focused private equity firm's first bet in the pharmaceutical space in India.
Read More
A quick synopsis of issues and areas entrepreneurs and organizations need to keep in mind to prosper in the new, tech-enabled terrain of healthcare. Healthcare has transformed itself post-Covid. Technology has come to the fore. Remote care, wearables and digital accessories are the new norm.
Read More
Earlier this month, the debut fund of healthcare-focused private equity firm Somerset Indus Capital Partners made its first partial exit via an initial public offering (IPO) from Krsnaa Diagnostics. Previously, Somerset fully exited Sandor Medicaids in 2016 via a secondary deal and partially exited Cygnus Hospitals via a strategic transaction in January 2020.
Read More
Amid all the challenges, technology-enabled solutions will be key to accessible healthcare for all as it offers opportunities to streamline processing and improving overall patient experience..
Read More
1 2 3 8